News from the Northeast Node
On Thursday, May 18, 2017, the Northeast Node hosted its bi-monthly Science Series with a presentation by Dr. Steven H. Chapman on integrating the SBIRT (Screening, Brief Intervention, Referral to Treatment) model into a pediatric primary care practice.
In his roles as medical director of Boyle Community Pediatrics, physician at the Children’s Hospital at Dartmouth (CHaD), and President of the New Hampshire Pediatric Society, Dr. Chapman and his team have worked to integrate the SBIRT model into practice flow, allowing them to identify adolescents who may be at-risk or in need of additional services for substance use and mental health problems.
Nationally, pediatricians receive over 200 discrete health advice directives for patient visits, and if a pediatrician were to follow all of those, a 4-year-old well child visit would last three and a half hours. By integrating a screening tool, performing a brief intervention, and referring to internal or external treatments when needed, doctors can individualize treatment while still meeting the intentions of those directives.
Many practices don’t screen patients for substance use and mental health problems because they perceive it to take up too much time, but Dr. Chapman and his team have worked to integrate the screening process to be done in the waiting room, so patients and providers are more prepared to discuss these problems and how they are impacting the patient’s life and larger health picture without sacrificing valuable clinic time. The screener is completed on a tablet and is integrated into the e lectronic medical record.
Dr. Chapman, who was recently named President of the New Hampshire Pediatric Society, is a Core Investigator of the Northeast Node.
A recording of this Science Series presentation can be found on our website. Follow the Northeast Node on Twitter and Facebook.
Update from the Addiction Technology Transfer Center (ATTC)
ATTC Messenger May 2017: Hepatitis Awareness Month: Researcher Dr. Ryan Westergaard Studies the Factors that Help Patients Remain in Treatment.
ATTC/NIATx Service Improvement Blog: Marijuana Legalization is a Process and We Haven't Reached the Midway Point.
Two upcoming events: (see more on these below)
National Cannabis Summit, August 28-30, Denver, CO.
National Frontier and Rural ATTC 5th Annual Technology Summit, July 27-29, Reno, NV.
More from the ATTC. . .
News from the New England Consortium Node
Addictions 2017 Conference
Researchers affiliated with the New England Consortium Node recently delivered talks at the Addictions 2017 Conference presented by McLean Hospital, Division of Alcohol and Drug Abuse and held in Cambridge, MA on May 5-6.
The conference was a well-attended event with over 400 attendees from Massachusetts, New England, the northeast, as well as from other parts of the world, including Brazil. Kimberly A. Johnson, Ph.D., Director of the Center for Substance Abuse Treatment at SAMHSA was the keynote speaker on the first day of the conference and delivered an engaging presentation on "What is High-Quality Treatment for Substance Use Disorders?"
Roger Weiss, MD (McLean Hospital/Harvard Medical School) presented a talk on "Pharmacotherapy for Alcohol Use Disorders." Shelly F. Greenfield, MD, MPH (McLean Hospital/Harvard Medical School) presented a talk on "Treating Women with Substance Use Disorders." Hilary Connery, MD, PhD (McLean Hospital/Harvard Medical School) delivered a talk on "Medication Treatment for Opioid Use Disorders." Richard Saitz, MD, MPH (Boston University School of Medicine) presented a talk on "Brief Interventions for Unhealthy Substance Use: What is the Evidence."
CTN-0069 Opioid Use Disorder in the Emergency Department Study
Gail D’Onofrio, M.D., M.S. along with David Fiellin, M.D. and their team at Yale University are leading the CTN-0069 protocol Opioid Use Disorder in the Emergency Department. Together with staff from EMMES and NIDA, study training was completed in April and Johns Hopkins Hospital enrolled their first patient on 4/11/2017.
News from the CTN DSC & CCC at EMMES
The 38th Annual Meeting of the Society for Clinical Trials was held from May 15-18 in Liverpool, United Kingdom.
The meeting was well attended by experts and professionals from academia, the pharmaceutical and device industries, government agencies, and clinical research entities.
Our Emmes staff (DSC and CCC) had good representation at this meeting this year; a total of 7 abstracts were accepted from the team, who presented posters and paper sessions.
Topics of the 7 posters and presentations included: best practices for study drug management, considering sex as a biological variable in research design/analysis/reporting, informed consent processes, the CTN's training documentation form, leveraging electronic data capture, tailoring a website to support a clinical research network, and quality control of DSTM domain mappings.
To view a complete list of the posters and papers, click here. . .